HEOR - Polygon Health Analytics

The Million-Dollar Slide: A Sharper Way to Think About Real-World Data Quality

Jul 05, 2026

by Lixia Yao, PhD At the DIA 2026 Annual Meeting, I sat through hundreds of slides. Most conveyed useful information. A few introduced new ideas. But...

A 5-Minute Guide to Medicare Drug Price Negotiation Under the IRA

May 16, 2026

Prescription drug pricing in the United States has long been a focal point of health policy debate. For Medicare beneficiaries, particularly older adults and individuals living...

Polygon Health Analytics Showcases AI-Driven SLE Research and Social Media Evidence at ISPOR 2026

May 03, 2026

Philadelphia, PA — Polygon Health Analytics LLC will present new research and lead an interactive workshop at the ISPOR 2026 Annual Conference, May 17–20, 2026, at...

AI in HEOR, RWD & Medical Affairs: What 133 Professionals Told Us—and What It Means for the Industry

Apr 14, 2026

Artificial intelligence is gaining traction across many disciplines, and health economics and outcomes research (HEOR), real-world data (RWD), and medical affairs are no exception. To understand...

Will AI Replace Pathologists? -Notes From the 2026 USCAP Floor

Mar 28, 2026

“People should stop training radiologists now.” — Geoffrey Hinton (2016; he later conceded the timeline was wrong) “Within 10 years, AI will replace many doctors…” — Bill Gates,...

Synthetic Data vs. Real-World Data: A Reality Check for Healthcare AI

Dec 15, 2025

I first encountered the concept of synthetic data back in 2013, while teaching a health informatics course as a tenure-track assistant professor at UNC Charlotte. To...

Drug Development Program Done Right: A Practical Checklist to Prevent Strategic Blind Spots

Nov 28, 2025

In the high-stakes world of pharmaceutical R&D, thousands of drug candidates are abandoned every year long before reaching patients. The harsh reality: fewer than...

QALYs Explained: The Metric That’s Shaping—and Dividing—Healthcare Policy

Nov 10, 2025

Quality-Adjusted Life Years (QALYs) are a cornerstone concept in health economics. They measure the value of medical treatments by considering both how long people live and...

Value-Based Health Care: Shifting the Focus from Quantity to Quality

Oct 23, 2025

Understand how value-based health care shifts focus from volume to outcomes, rewarding better results, reducing costs and improving patient care....

Budget Impact Models: A Practical Tool for Healthcare Decision-Making

Oct 07, 2025

Learn how Budget Impact Models help payers and HTA agencies assess short-term affordability of new healthcare treatments alongside cost-effectiveness analysis....

New White Paper: Charting the Landscape of Real-World Data in the U.S.

Oct 01, 2025

Learn how real-world data is transforming U.S. healthcare and life sciences. Our new white paper maps datasets, applications, challenges, and future directions....

Chart showing global vaccine trial trends

Polygon Health Analytics Launches Vaccine Trial Atlas: Making Clinical Trial Data Accessible

Sep 16, 2025

The vaccine research and development community has faced unprecedented challenges in recent months, including policy upheavals, leadership changes, research program cancellations, and a surge of misinformation...